Morgan Stanley analyst Dara Mohsenian lowered the firm’s price target on Olaplex (OLPX) to $1.40 from $1.75 and keeps an Equal Weight rating on the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLPX:
- Olaplex price target lowered to $1.25 from $1.50 at Barclays
- Olaplex Holdings: Hold Rating Amid Turnaround Progress and Competitive Challenges
- Olaplex Earnings Call: Mixed Sentiment Amid Challenges
- Olaplex Holdings: Strong Q3 Performance and Strategic Innovations Support Buy Rating
- Olaplex Holdings Reports Mixed Q3 2025 Results